drugset / Trial / NCT00771368

Reduction of Bacteria in MRSA Positive Ulcers

NCT00771368

Phase 1/2 Terminated 20 enrolled Nitric BioTherapeutics, Inc
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if gaseous nitric oxide is effective in the treatement of bacteria in MRSA positive ulcers

Timeline

Start
2009-01
Primary completion
2009-05
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 1 % Topical